HDLC HDL-CHOLESTEROL PLUS 3RD GENERATION

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-05-18 for HDLC HDL-CHOLESTEROL PLUS 3RD GENERATION manufactured by Roche Diagnostics.

Event Text Entries

[75520958] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[75520959] The customer questioned results for 1 patient tested for ldl_c ldl-cholesterol plus 2nd generation (ldl_c), total cholesterol, hdl, and trig on a cobas 8000 c 702 module. Based on the information provided, the hdl and ldl_c results were erroneous and reported outside of the laboratory. The date of event was requested but has not been provided. This medwatch will cover hdl. Refer to medwatch with patient identifier (b)(6) for information on the ldl_c erroneous results. The initial hdl result from the c702 module was 10 (unit of measure not provided). The repeat hdl result using sekisui reagent was 45 (unit of measure not provided). The initial ldl_c result from the c702 module was 54 (unit of measure not provided). The repeat ldl result using sekisui reagent was 713 (unit of measure not provided). Both sets of results were reported outside of the laboratory with a note indicating that the sekisui results were performed using a different assay and that there was suspected lp(x) interference. No adverse event occurred. The patient was not affected due to the roche results. The patient sample was then tested by electrophoresis where the alpha? Fraction was 0. 9, the free beta-fraction was 13. 3 and the beta-fraction was 85. 8. Based on the reference ranges, the beta-fraction result of 85. 8 was high and hyperlipoproteinemia was suspected. The c702 module serial number was not provided.
Patient Sequence No: 1, Text Type: D, B5


[75532525] The date of event is an approximate date; the customer stated the event occurred in (b)(6) 2016. The unit of measure for total cholesterol, trig, hdl, ldl_c was mg/dl.
Patient Sequence No: 1, Text Type: N, H10


[76284892]
Patient Sequence No: 1, Text Type: N, H10


[132591351] A specific root cause was not identified. Additional related test results were requested for investigation but could not be provided. The patient has hepatitis, vanishing bile duct syndrome and osteoporosis in both knees. In patients with these conditions, the presence of lp(x) and/or lp(y) lipoproteins can be assumed. These proteins can only be observed using a particular type of lipoprotein electrophoresis. These particles are not detected or barely detected in roche's ldlc3 assay. With changed liver patterns, it is possible that different direct test methods give very different results depending on the sensitivity to abnormal lipoproteins.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-01025
MDR Report Key6574756
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-05-18
Date of Report2017-08-03
Date of Event2016-01-01
Date Mfgr Received2017-04-27
Date Added to Maude2017-05-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameHDLC HDL-CHOLESTEROL PLUS 3RD GENERATION
Generic NameLDL & VLDL PRECIPITATION, CHOLESTEROL VIA ESTERASE-OXIDASE, HDL
Product CodeLBS
Date Received2017-05-18
Model NumberNA
Catalog NumberASKU
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-05-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.